NFX.L
Nuformix plc
Latest RNS
Powered by Vox Markets
- Nuformix PLC - Appointment of Dr Karl Keegan
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Notification of Major Holdings
- Nuformix PLC - Operational Update
- Nuformix PLC - Resignation of Dave Tapolczay
- Nuformix PLC - Director Dealing
- Nuformix PLC - Notification of Major Holdings
- Nuformix PLC - Resignation of John Lidgey
- Nuformix PLC - Major Shareholding Notification
- Nuformix PLC - Amendment to Notice
- Nuformix PLC - Issue of Equity
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Half-year Report
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Update and Placing Announcement
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Issue of Equity
- Nuformix PLC - Statement re. Share Price Movement
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - AGM Results
- Nuformix PLC - Directorate Change
- Nuformix PLC - Ebers Cannabinoid Collaboration Update
- Nuformix PLC - Appointment of Dr Muhunthan Thillai
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Annual Financial Report
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Final Results
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Positive Results for NXP001 Clinical Trial
- Nuformix PLC - Holding(s) in Company - Amendment
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Loan Conversion
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Nuformix Achieves 2nd NXP001 Development Milestone
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Strategic Cannabinoid Agreement
- Nuformix PLC - Notification Major Share Interests
- Nuformix PLC - Nuformix Commences NXP001 Clinical Trial
- Nuformix PLC - MHRA approval for NXP001
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Unaudited Half Year Results
- Nuformix PLC - Reports Results from Novel IPF Pre-Clinical Trial
- Nuformix PLC - Expansion of NXP001 Agreement & Milestone Payment
- Nuformix PLC - Director/PDMR Shareholding
- Nuformix PLC - Additional New NXP002 Patent Filing
- Nuformix PLC - Result of AGM
- Nuformix PLC - NXP001 Pre-Clinical Milestone Achieved
- Nuformix PLC - Convertible Loan Amendment
- Nuformix PLC - Annual Report and Notice of AGM
- Nuformix PLC - Final Results
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Operational Update
- Nuformix PLC - Collaboration with SGSC
- Nuformix PLC - Dr Chris Blackwell Appointed NED
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Stmnt re Share Price Movement
- Nuformix PLC - Update re: Broker
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Agreement to License NXP001
- Nuformix PLC - Dr Andy Richards Chairs Advisory Panel - New Appts
- Nuformix PLC - Second Price Monitoring Extn
- Nuformix PLC - Price Monitoring Extension
- Nuformix PLC - Grant of Warrants
- Nuformix PLC - Appointment of Broker
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - Holding(s) in Company
- Nuformix PLC - NXP001 agreement for pilot bioequivalence study
- Nuformix PLC - Admission and First Dealings
- Nuformix PLC - Cancellation Notice and Re-Admission